Activation of Akt and cardioprotection against reperfusion injury are maximal with only five minutes of sevoflurane postconditioning in isolated rat hearts

Journal of Zhejiang University: Science B

Volumn 14, Issue 6, 2013, Pages 511-517

  Yao, Yuan Yuan ^a   Zhu, Man Hua ^b   Zhang, Feng Jiang ^a   Wen, Chuan Yun ^b   Ma, Lei Lei ^a   Wang, Wen Na ^a   Wang, Can Can ^b   Liu, Xian Bao ^a   Yu, Li Na ^a   Qian, Ling Bo ^c   Wang, Jian An ^a   Yan, Min ^a,b  

^a ZHEJIANG UNIVERSITY   (China)

^b XUZHOU MEDICAL UNIVERSITY   (China)

^c ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Akt; Cardioprotection; Duration of administration; Ischemia reperfusion (I R) injury; Sevoflurane postconditioning

Indexed keywords

PROTEIN KINASE B; SEVOFLURANE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HEART; HEART INFARCTION SIZE; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE CONTRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART PROTECTION; HEMODYNAMICS; ISCHEMIC POSTCONDITIONING; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; UPREGULATION;

ANIMALS; CARDIOTONIC AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; MALE; METHYL ETHERS; MYOCARDIAL REPERFUSION INJURY; PLATELET AGGREGATION INHIBITORS; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RATS, SPRAGUE-DAWLEY; TREATMENT OUTCOME;

RATTUS;

EID: 84879315245     PISSN: 16731581     EISSN: 18621783     Source Type: Journal    
DOI: 10.1631/jzus.B1200195     Document Type: Article

References (21)

1. Cantley, L.C., 2002. The phosphoinositide 3-kinase pathway. Science, 296(5573):1655-1657. [doi:10.1126/science.296.5573.1655]
2. Chen, H.T., Yang, C.X., Li, H., Zhang, C.J., Wen, X.J., Zhou, J., Fan, Y.L., Huang, T., Zeng, Y.M., 2008. Cardioprotection of sevoflurane postconditioning by activating extracellular signal-regulated kinase 1/2 in isolated rat hearts. Acta Pharmacol. Sin., 29(8):931-941. [doi:10.1111/j.1745- 7254.2008.00824.x]
3. Chiari, P.C., Bienengraeber, M.W., Pagel, P.S., Krolikowski, J.G., Kersten, J.R., Warltier, D.C., 2005. Isoflurane protects against myocardial infarction during early reperfusion by activation of phosphatidylinositol-3- kinase signal transduction: evidence for anesthetic-induced postconditioning in rabbits. Anesthesiology, 102(1):102-109. [doi:10.1097/00000542-200501000-00018]
4. Feng, J., Fischer, G., Lucchinetti, E., Zhu, M., Bestmann, L., Jegger, D., Arras, M., Pasch, T., Perriard, J.C., Schaub, M.C., et al., 2006. Infarct-remodeled myocardium is receptive to protection by isoflurane postconditioning: role of protein kinase b/Akt signaling. Anesthesiology, 104(5):1004-1014. [doi:10.1097/00000542-200605000-00017]
5. He, W., Zhang, F.J., Wang, S.P., Chen, G., Chen, C.C., Yan, M., 2008. Postconditioning of sevoflurane and propofol is associated with mitochondrial permeability transition pore. J. Zhejiang Univ.-Sci. B, 9(2):100-108. [doi:10.1631/jzus.B0710586]
6. Inamura, Y., Miyamae, M., Sugioka, S., Domae, N., Kotani, J., 2010. Sevoflurane postconditioning prevents activation of caspase 3 and 9 through antiapoptotic signaling after myocardial ischemia-reperfusion. J. Anesth., 24(2): 215-224. [doi:10.1007/s00540-010-0877-6]
7. Kazama, T., Ikeda, K., 1988. Comparison of MAC and the rate of rise of alveolar concentration of sevoflurane with halothane and isoflurane in the dog. Anesthesiology, 68(3):435-437. [doi:10.1097/00000542-198803000-00020]
8. Ladilov, Y.V., Balser, C., Piper, H.M., 1998. Protection of rat cardiomyocytes against simulated ischemia and reoxygenation by treatment with protein kinase C activator. Circul. Res., 82(4):451-457. [doi:10.1161/01.RES.82. 4.451]
9. Landoni, G., Biondi-Zoccai, G.G., Zangrillo, A., Bignami, E., D'Avolio, S., Marchetti, C., Calabro, M.G., Fochi, O., Guarracino, F., Tritapepe, L., et al., 2007. Desflurane and sevoflurane in cardiac surgery: a meta-analysis of randomized clinical trials. J. Cardiothorac. Vasc. Anesth., 21(4):502-511. [doi:10.1053/j.jvca.2007.02.013]
10. Obal, D., Preckel, B., Scharbatke, H., Mullenheim, J., Hoterkes, F., Thamer, V., Schlack, W., 2001. One MAC of sevoflurane provides protection against reperfusion injury in the rat heart in vivo. Br. J. Anaesth., 87(6): 905-911. [doi:10.1093/bja/87.6.905]
11. Obal, D., Scharbatke, H., Barthel, H., Preckel, B., Mullenheim, J., Schlack, W., 2003. Cardioprotection against reperfusion injury is maximal with only two minutes of sevoflurane administration in rats. Can. J. Anaesth., 50(9):940-945. [doi:10.1007/BF03018744]
12. Pravdic, D., Mio, Y., Sedlic, F., Pratt, P.F., Warltier, D.C., Bosnjak, Z.J., Bienengraeber, M., 2010. Isoflurane protects cardiomyocytes and mitochondria by immediate and cytosol-independent action at reperfusion. Br. J. Pharmacol., 160(2):220-232. [doi:10.1111/j.1476-5381.2010.00698.x]
13. Redel, A., Stumpner, J., Tischer-Zeitz, T., Lange, M., Smul, T.M., Lotz, C., Roewer, N., Kehl, F., 2009. Comparison of isoflurane-, sevoflurane-, and desflurane-induced pre- and postconditioning against myocardial infarction in mice in vivo. Exp. Biol. Med. (Maywood), 234(10): 1186-1191. [doi:10.3181/0902-RM-58]
14. Sakai, E.M., Connolly, L.A., Klauck, J.A., 2005. Inhalation anesthesiology and volatile liquid anesthetics: focus on isoflurane, desflurane, and sevoflurane. Pharmacotherapy, 25(12):1773-1788. [doi:10.1592/phco.2005.25. 12.1773]
15. Siegmund, B., Schlack, W., Ladilov, Y.V., Balser, C., Piper, H.M., 1997. Halothane protects cardiomyocytes against reoxygenation-induced hypercontracture. Circulation, 96(12):4372-4379. [doi:10.1161/01.CIR.96.12.4372]
16. Smul, T.M., Lange, M., Redel, A., Stumpner, J., Lotz, C.A., Roewer, N., Kehl, F., 2009. Desflurane-induced cardioprotection against ischemia-reperfusion injury depends on timing. J. Cardiothorac. Vasc. Anesth., 23(5):600-606. [doi:10.1053/j.jvca.2008.11.004]
17. Wallin, R.F., Regan, B.M., Napoli, M.D., Stern, I.J., 1975. Sevoflurane: a new inhalational anesthetic agent. Anesth. Analg., 54(6):758-766. [doi:10.1213/00000539-197511000-00021]
18. Yao, Y.T., Fang, N.X., Shi, C.X., Li, L.H., 2010a. Sevoflurane postconditioning protects isolated rat hearts against ischemia-reperfusion injury. Chin. Med. J. (Engl.), 123(10):1320-1328.
19. Yao, Y.T., Li, L.H., Chen, L., Wang, W.P., Li, L.B., Gao, C.Q., 2010b. Sevoflurane postconditioning protects isolated rat hearts against ischemia-reperfusion injury: the role of radical oxygen species, extracellular signal-related kinases 1/2 and mitochondrial permeability transition pore. Mol. Biol. Rep., 37(5):2439-2446. [doi:10.1007/s11033-009-9755-4]
20. Yu, L.N., Yu, J., Zhang, F.J., Yang, M.J., Ding, T.T., Wang, J.K., He, W., Fang, T., Chen, G., Yan, M., 2010. Sevoflurane postconditioning reduces myocardial reperfusion injury in rat isolated hearts via activation of PI3K/Akt signaling and modulation of bcl-2 family proteins. J. Zhejiang Univ.-Sci. B (Biomed. & Biotechnol.), 11(9):661-672. [doi:10.1631/jzus.B1000155]
21. Zheng, Z., Yang, M., Zhang, F., Yu, J., Wang, J., Ma, L., Zhong, Y., Qian, L., Chen, G., Yu, L., et al., 2011. Gender-related difference of sevoflurane postconditioning in isolated rat hearts: focus on phosphatidylinositol-3-kinase/akt signaling. J. Surg. Res., 170(1):e3-e9. [doi:10.1016/j.jss.2011.04.035]